`
`Druga@FDA: FDA.Appm.ed Drug PnxlJcts
`
`EPA Home3 Drug Databa5es4 Drugst!EOA5
`Drugs@F
`
`FDA Approved Drug Products
`
`FAQ6 I Jnstn~ctions7 I Glouary8 I Contact Us9
`
`~ErTeil Unk
`
`Start Over
`
`Back to Search Results
`
`Back to Overview
`
`Drug Details
`
`Dn.~g Name(s)
`FDA Application No.
`Active Jngredlent(s)
`Company
`Ortglnal Approval or Tentative Approval Data
`Chemical Type
`Review Classlftcatlon
`
`VOL TAREN
`(NDA) 020037
`DICLOFENAC SODIUM
`NOVARDS
`March 28, 1991
`3 New dosage fonn
`P Prfortty review dn~g
`
`• 1harapeutlc Equivalents
`
`• Label Information
`
`• Approval History, Letters, Ravla'WS, and Related
`Documents
`
`Products on Application (NDA) #020037
`Click on a column header to ra-sort the table:
`
`Ol'\lg Nama Active Ingredients
`
`Strength Dosage Fonn/~uta
`
`VOLTAREN
`
`DICLOFENAC SODIUM
`
`0.1 o/o
`
`SOLUTION/DROPS; OPHTHALMIC
`
`Marketing
`status
`Prescription
`
`RI.D TE
`Coda
`Yes AT
`
`Back to Top I Back to Previous Page I Back to Drugs@FDA Home
`
`Disclaimer-1°
`
`FDA/Center for Drug Evaluation and Research
`Office of Corrm.~nlcatlons
`Division of Online Corrm.~nications
`Update Frequency: Daily
`
`Unka on tills page:
`1. http://www. addthis. c om'bookma rk.php?u508=t rue&v =152&usema me =fda rna in
`
`2. http://www. addthls. c omtbookma rk.php
`
`3. http://www. fda.govjdefault. htm
`
`4. http://www. fda .gov/Drugs/Infonnat ionOnDrugs/default. htm
`
`5. http :lfwww. access data. fda. gov /sc ripts/cder/drugsatfda/index. cfm
`
`6. http://www. fda .gov/Drugs/InfonnatlonOnDrugs/uc rrCI75234. htm
`
`7. http://www. fda .gov/Drugs/InfonnatlonOnDrugs/UCM079874
`
`8. http://www. fda .gov/Drugs/InfonnationOnDrugs/uc rrCI79436.htm
`
`9. http://www. ac cessdata. fda. gov/scripts/en-eiVcder/commentdrugcat. cfm
`
`10. http://www. fda .gov/ About FDA/ AboutThlsWebslte/WebsltePollcles/default. htm#web
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`Accesslblllty Contact FDA careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`hUp:/Jw.\w.accessdatafda.goiscripls/cder/d"ugsalfd&irdax.cfm?fuseactim=Sardl.Drug Details
`
`112
`
`Innopharma EX1027, Page 1
`
`
`
`212412014
`U.S. Food and Drug Admnistration
`10903 New Halll'Shire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Email FDA
`
`Drugs@FDA: FDAApprCMld Drug Products
`
`For Government For Press
`Corrbination Products Advisory Corrflittees Science & Research Regulatory Information Safety Emergency Preparedness
`International Programs News & Events Training and Continuing Education Inspections/Colll'liance State & Local Officials
`Consumers Industry Health Professionals FDA Archive
`.<f{. U.S. Department of Healtfl & Human Services
`
`Links on this page:
`1. http://www.addthis.corrY'bookmark.php?u508=true&v=152&username=fdamain
`
`2. http://www.addthis.corrY'bookmark.php
`
`3. http://www.fda.gov/default.htm
`
`4. http :1/www. fda .gov /Drugs/InformationOnDrugs/default. htm
`5. http :1/www. ac cessdata. fda. gov I scripts/ c der/ drugsatfda/index. cfm
`
`6. http :1/www. fda .gov /Drugs/InformationOnDrugs/uc ntl75234. htm
`
`7. http:/ jwww. fda .gov /Drugs/InformationOnDrugs/UCM079874
`
`8. http://www. fda .gov /Drugs/InformationOnDrugs/uc ntl79436. htm
`
`9. http://www.accessdata.fda.gov/scripts/email/cder/commentdrugcat.cfm
`
`10. http://www.fda.gov/AboutFDA/AboutThisWebsite/WebsitePolicies/default.htm#web
`
`htlp:llw.\w.accessdata.fdagOIIscripls/cder/drugsatfdalindax.cfm?fuseaction=Search.DrugDetails
`
`2J2
`
`Innopharma EX1027, Page 2